Interpretation of PET scan results at varying degrees of blood glucose in diabetic patients with lymphoma: an experience of 25 cases of Non Hodgkin Lymphomas from southern India

Han HS, Escalón MP, Hsiao B, Serafini A, Lossos IS. High incidence of false-positive PET scans in patients with aggressive non- hodgkin’s lymphoma treated with rituximab-containing regimens. Ann Oncol. 2009;20:309–18. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer–a PET study. J Nucl Med. 1993;34:1–6. Zhuang HM, Cortes-Blanco A, Pourdehnad M, et al. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl Med Commun. 2001;22:1123–8. NCCN guidelines for management of lymphoma accessed via www.nccn.org last accessed on 10th Jan 2010. Gorenberg M, Hallett WA, O’Doherty MJ. Does diabetes affect [(18)F]FDG standardised uptake values in lung cancer? Eur J Nucl Med Mol Imaging. 2002;29:1324–7.